Fundraising Fox

EnteroTrack

Aurora, US · Founded 2013 · Colorado LLC · 15 employees on LinkedIn

EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.

Founders & leadership

EnteroTrack was founded in 2013 by Robin Shandas.

RSRobin Shandas
Robin ShandasinChief Executive Officer (CEO)
GTGlenn T. Furuta
Glenn T. FurutaChief Medical Officer (CMO)
SJSteven J. Ackerman
Steven J. AckermaninChief Scientific Officer (CSO)
JH
Jeffrey HarringtonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 2 rounds · 2014–2021

$4.7MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey HarringtonDirector
  • Steven AckermanDirector
  • Robin ShandasExecutive Officer, Director
  • Glenn FurutaDirector
Offering amount
$4.7M
Amount sold
$4.7M
First sale
May 2021
Incorporated
Limited Liability Company, Colorado
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedJul 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven AckermanDirector
  • Robin ShandasDirector
  • Glenn FurutaDirector
Offering amount
$500K
Amount sold
$250K
Minimum investment
$250K
First sale
May 2014
Incorporated
Limited Liability Company, Colorado, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with EnteroTrack for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does EnteroTrack do?
EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
Who founded EnteroTrack?
EnteroTrack was founded by Robin Shandas in 2013.
How much funding has EnteroTrack raised?
EnteroTrack has disclosed $4.9M raised across 2 rounds.
Where is EnteroTrack headquartered?
EnteroTrack is headquartered in Aurora, US.